This inventor holds 1 USPTO granted patent. Top assignee: Macau University of Science and Technology. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Innovations in Neurodegenerative Disease Treatment: The Patents of Jing Fu
Introduction: Jing Fu, a remarkable inventor based in Macau, CN, has made significant strides in the field of neurodegenerative disease treatment. With one patent to his name, he demonstrates a commitment to advancing medical science through innovative solutions.
Latest Patents: Jing Fu's patent, titled "Lignanamides and a Method of Treating Neurodegenerative Diseases by Using the Same," represents a groundbreaking approach to addressing these complex conditions. The patent focuses on a lignanamide that includes a benzo-angular triquinane skeleton. Specifically, the lignanamide is represented by formula (I) and any derivative of this formula, where R may be either —OH or —OCH3. Furthermore, this patent outlines a method of treating neurodegenerative diseases by administering the lignanamide to individuals in need.
Career Highlights: As an inventor, Jing Fu plays a significant role at the Macau University of Science and Technology. His work in the academic environment fosters research and innovation, contributing to the development of effective treatments for neurodegenerative diseases.
Collaborations: Throughout his career, Jing Fu has collaborated with prominent colleagues such as Guo-Yuan Zhu and Zhi-Hong Jiang. These partnerships enhance his research endeavors and contribute to a richer understanding of neurodegenerative diseases.
Conclusion: Jing Fu stands out as a talented inventor addressing the urgent needs in the realm of neurodegenerative disease treatments. Through his patent and ongoing collaborations, he continues to propel innovations that may significantly impact the lives of many individuals suffering from these conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile